Overview

Efficacy and Safety Assessment of T4032 Versus Lumigan® in Ocular Hypertensive or Glaucomatous Patients

Status:
Completed
Trial end date:
2021-02-24
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and safety of T4032 versus Lumigan.
Phase:
Phase 3
Details
Lead Sponsor:
Laboratoires Thea
Treatments:
Bimatoprost